Abstract
Manganese (Mn) exposure is associated with increased risks of dementia and cerebrovascular disease. However, evidence regarding the impact of ambient Mn exposure on brain imaging markers is scarce. We aimed to investigate the association between ambient Mn exposure and brain imaging markers representing neurodegeneration and cerebrovascular lesions. We recruited a total of 936 adults (442 men and 494 women) without dementia, movement disorders, or stroke from the Republic of Korea. Ambient Mn concentrations were predicted at each participant’s residential address using spatial modeling. Neurodegeneration-related brain imaging markers, such as the regional cortical thickness, were estimated using 3 T brain magnetic resonance images. White matter hyperintensity volume (an indicator of cerebrovascular lesions) was also obtained from a certain number of participants (n = 397). Linear regression analyses were conducted after adjusting for potential confounders. A log-transformed ambient Mn concentration was associated with thinner parietal (β = −0.02 mm; 95% confidence interval [CI], −0.05 to −0.01) and occipital cortices (β = −0.03 mm; 95% CI, −0.04 to −0.01) after correcting for multiple comparisons. These associations remained statistically significant in men. An increase in the ambient Mn concentration was also associated with a greater volume of deep white matter hyperintensity in men (β = 772.4 mm3, 95% CI: 36.9 to 1508.0). None of the associations were significant in women. Our findings suggest that ambient Mn exposure may induce cortical atrophy in the general adult population.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hengstler JG, Bolm-Audorff U, Faldum A, Janssen K, Reifenrath M, Götte W, et al. Occupational exposure to heavy metals: DNA damage induction and DNA repair inhibition prove co-exposures to cadmium, cobalt and lead as more dangerous than hitherto expected. Carcinogenesis. 2003;24:63–73. https://doi.org/10.1093/carcin/24.1.63.
Klaassen CD. Casarett and Doull’s toxicology: the basic science of poisons. Ninth edition. ed. New York: McGraw-Hill Education; 2019.
Balali-Mood M, Naseri K, Tahergorabi Z, Khazdair MR, Sadeghi M. Toxic mechanisms of five heavy metals: mercury, lead, chromium, cadmium, and arsenic. Front Pharmacol. 2021;12:643972. https://doi.org/10.3389/fphar.2021.643972.
Witkowska D, Slowik J, Chilicka K. Heavy metals and human health: possible exposure pathways and the competition for protein binding sites. Molecules. 2021;26. https://doi.org/10.3390/molecules26196060.
Vetrimurugan E, Brindha K, Elango L, Ndwandwe OM. Human exposure risk to heavy metals through groundwater used for drinking in an intensively irrigated river delta. Appl Water Sci. 2017;7:3267–80. https://doi.org/10.1007/s13201-016-0472-6
Sharma SD. Risk assessment via oral and dermal pathways from heavy metal polluted water of Kolleru lake - A Ramsar wetland in Andhra Pradesh, India. Environ Anal Health Toxicol. 2020;35:e2020019. https://doi.org/10.5620/eaht.2020019.
Nemery B. Metal toxicity and the respiratory tract. Eur Respir J. 1990;3:202–19.
Kim JH, Byun HM, Chung EC, Chung HY, Bae ON. Loss of integrity: impairment of the blood-brain barrier in heavy metal-associated ischemic stroke. Toxicol Res. 2013;29:157–64. https://doi.org/10.5487/TR.2013.29.3.157.
Gundacker C, Hengstschlager M. The role of the placenta in fetal exposure to heavy metals. Wien Med Wochenschr. 2012;162:201–6. https://doi.org/10.1007/s10354-012-0074-3.
Tuschl K, Mills PB, Clayton PT. Manganese and the brain. Int Rev Neurobiol. 2013;110:277–312. https://doi.org/10.1016/B978-0-12-410502-7.00013-2.
O’Neal SL, Zheng W. Manganese toxicity upon overexposure: a decade in review. curr environ. Health Rep. 2015;2:315–28. https://doi.org/10.1007/s40572-015-0056-x.
Lee EY, Flynn MR, Lewis MM, Mailman RB, Huang X. Welding-related brain and functional changes in welders with chronic and low-level exposure. Neurotoxicology. 2018;64:50–9. https://doi.org/10.1016/j.neuro.2017.06.011.
Antonini JM, Santamaria AB, Jenkins NT, Albini E, Lucchini R. Fate of manganese associated with the inhalation of welding fumes: potential neurological effects. Neurotoxicology. 2006;27:304–10. https://doi.org/10.1016/j.neuro.2005.09.001.
Lin G, Li X, Cheng X, Zhao N, Zheng W. Manganese exposure aggravates beta-amyloid pathology by microglial activation. Front Aging Neurosci. 2020;12:556008. https://doi.org/10.3389/fnagi.2020.556008.
Sharma A, Feng L, Muresanu DF, Sahib S, Tian ZR, Lafuente JV, et al. Manganese nanoparticles induce blood-brain barrier disruption, cerebral blood flow reduction, edema formation and brain pathology associated with cognitive and motor dysfunctions. Prog Brain Res. 2021;265:385–406. https://doi.org/10.1016/bs.pbr.2021.06.015.
Saar G, Koretsky AP. Manganese enhanced MRI for use in studying neurodegenerative diseases. Front Neural Circuits. 2019;12. https://doi.org/10.3389/fncir.2018.00114.
Noh Y, Jeon S, Lee JM, Seo SW, Kim GH, Cho H, et al. Anatomical heterogeneity of Alzheimer disease: based on cortical thickness on MRIs. Neurology. 2014;83:1936–44. https://doi.org/10.1212/WNL.0000000000001003.
Cho J, Noh Y, Kim SY, Sohn J, Noh J, Kim W, et al. Long-term ambient air pollution exposures and brain imaging markers in korean adults: the environmental pollution-induced neurological EFfects (EPINEF) study. Environ Health Perspect. 2020;128:117006. https://doi.org/10.1289/EHP7133.
Manek E, Petroianu GA. Brain delivery of antidotes by polymeric nanoparticles. J Appl Toxicol. 2021;41:20–32. https://doi.org/10.1002/jat.4029.
McDuffie EE, Martin RV, Spadaro JV, Burnett R, Smith SJ, O’Rourke P, et al. Source sector and fuel contributions to ambient PM2.5 and attributable mortality across multiple spatial scales. Nat Commun. 2021;12:3594. https://doi.org/10.1038/s41467-021-23853-y.
Sampson PD, Richards M, Szpiro AA, Bergen S, Sheppard L, Larson TV, et al. A regionalized national universal kriging model using Partial Least Squares regression for estimating annual PM2.5 concentrations in epidemiology. Atmos Environ (1994). 2013;75:383–92. https://doi.org/10.1016/j.atmosenv.2013.04.015.
Kim SY, Song I. National-scale exposure prediction for long-term concentrations of particulate matter and nitrogen dioxide in South Korea. Environ Pollut. 2017;226:21–9. https://doi.org/10.1016/j.envpol.2017.03.056.
Sedgwick P. Limits of agreement (Bland-Altman method). BMJ. 2013;346:f1630. https://doi.org/10.1136/bmj.f1630.
Rubino A, Assogna F, Piras F, Di Battista ME, Imperiale F, Chiapponi C, et al. Does a volume reduction of the parietal lobe contribute to freezing of gait in Parkinson’s disease? Parkinsonism Relat Disord. 2014;20:1101–3. https://doi.org/10.1016/j.parkreldis.2014.07.002.
Pelizzari L, Di Tella S, Rossetto F, Laganà MM, Bergsland N, Pirastru A, et al. Parietal perfusion alterations in parkinson’s disease patients without dementia. Front Neurol. 2020;11. https://doi.org/10.3389/fneur.2020.00562.
Bharti K, Suppa A, Tommasin S, Zampogna A, Pietracupa S, Berardelli A, et al. Neuroimaging advances in Parkinson’s disease with freezing of gait: A systematic review. Neuroimage Clin. 2019;24:102059. https://doi.org/10.1016/j.nicl.2019.102059.
Marquez JS, Hasan SMS, Siddiquee MR, Luca CC, Mishra VR, Mari Z, et al. Neural correlates of freezing of gait in Parkinson’s disease: an electrophysiology mini-review. Front Neurol. 2020;11:571086. https://doi.org/10.3389/fneur.2020.571086.
Kwakye GF, Paoliello MM, Mukhopadhyay S, Bowman AB, Aschner M. Manganese-induced parkinsonism and parkinson’s disease: shared and distinguishable features. Int J Environ Res Public Health. 2015;12:7519–40. https://doi.org/10.3390/ijerph120707519.
Kulshreshtha D, Ganguly J, Jog M. Manganese and movement disorders: a review. J Mov Disord. 2021;14:93–102. https://doi.org/10.14802/jmd.20123.
Racette BA, Nelson G, Dlamini WW, Prathibha P, Turner JR, Ushe M, et al. Severity of parkinsonism associated with environmental manganese exposure. Environ Health. 2021;20:27. https://doi.org/10.1186/s12940-021-00712-3.
Pieperhoff P, Südmeyer M, Dinkelbach L, Hartmann CJ, Ferrea S, Moldovan AS, et al. Regional changes of brain structure during progression of idiopathic Parkinson’s disease – A longitudinal study using deformation based morphometry. Cortex. 2022;151:188–210. https://doi.org/10.1016/j.cortex.2022.03.009
Silbert LC, Kaye J. Neuroimaging and cognition in Parkinson’s disease dementia. Brain Pathol. 2010;20:646–53. https://doi.org/10.1111/j.1750-3639.2009.00368.x.
Liu S, Seidlitz J, Blumenthal JD, Clasen LS, Raznahan A. Integrative structural, functional, and transcriptomic analyses of sex-biased brain organization in humans. Proc Natl Acad Sci U. S. A. 2020;117:18788–98. https://doi.org/10.1073/pnas.1919091117.
Cserbik D, Chen JC, McConnell R, Berhane K, Sowell ER, Schwartz J, et al. Fine particulate matter exposure during childhood relates to hemispheric-specific differences in brain structure. Environ Int. 2020;143:105933. https://doi.org/10.1016/j.envint.2020.105933.
Cole M, Bale, Thompson. What the hippocampus tells the HPA axis: hippocampal output attenuates acute stress responses via disynaptic inhibition of CRF+ PVN neurons. Neurobiology of Stress. 2022;20. https://doi.org/10.1016/j.ynstr.2022.100473.
Pines A. Alzheimer’s disease, menopause and the impact of the estrogenic environment. Climacteric. 2016;19:430–2. https://doi.org/10.1080/13697137.2016.1201319.
Henderson VW. Alzheimer’s disease: review of hormone therapy trials and implications for treatment and prevention after menopause. J Steroid Biochem Mol Biol. 2014;142:99–106. https://doi.org/10.1016/j.jsbmb.2013.05.010.
Davey DA. Alzheimer’s disease, dementia, mild cognitive impairment and the menopause: a ‘window of opportunity’? Womens Health (Lond). 2013;9:279–90. https://doi.org/10.2217/whe.13.22.
Kelly DM, Rothwell PM. Blood pressure and the brain: the neurology of hypertension. Pract Neurol. 2020;20:100–8. https://doi.org/10.1136/practneurol-2019-002269.
Di Chiara T, Del Cuore A, Daidone M, Scaglione S, Norrito RL, Puleo MG, et al. Pathogenetic Mechanisms of hypertension-brain-induced complications: focus on molecular mediators. Int J Mol Sci. 2022;23. https://doi.org/10.3390/ijms23052445.
Scuteri A, Antonelli, Incalzi R. Subclinical HMOD in hypertension: brain imaging and cognitive function. High Blood Press Cardiovasc Prev. 2022;29:577–83. https://doi.org/10.1007/s40292-022-00546-1.
Nordberg G, ScienceDirect. Handbook on the toxicology of metals. 3rd ed. Amsterdam; Boston: Academic Press; 2007.
Aschner M, Costa LG. Neurotoxicity of metals: old issues and new developments. Amsterdam, Netherlands; Oxford, England; Cambridge, Massachusetts: Elsevier; 2021.
Rabin O, Hegedus L, Bourre JM, Smith QR. Rapid brain uptake of manganese(II) across the blood-brain barrier. J Neurochem. 1993;61:509–17. https://doi.org/10.1111/j.1471-4159.1993.tb02153.x.
Bornhorst J, Wehe CA, Huwel S, Karst U, Galla HJ, Schwerdtle T. Impact of manganese on and transfer across blood-brain and blood-cerebrospinal fluid barrier in vitro. J Biol Chem. 2012;287:17140–51. https://doi.org/10.1074/jbc.M112.344093.
Garner CD, Nachtman JP. Manganese catalyzed auto-oxidation of dopamine to 6-hydroxydopamine in vitro. Chem Biol Interact. 1989;69:345–51. https://doi.org/10.1016/0009-2797(89)90120-8.
Oulhote Y, Mergler D, Bouchard MF. Sex- and age-differences in blood manganese levels in the U.S. general population: national health and nutrition examination survey 2011-2012. Environ Health. 2014;13:87. https://doi.org/10.1186/1476-069X-13-87.
Funding
This work was supported by the Korea Environment Industry & Technology Institute (KEITI) through the Core Technology Development Project for Environmental Diseases Prevention and Management, funded by the Korea Ministry of Environment (MOE) (grant No.2022003310011), and a faculty research grant (grant No. 6-2021-0245) from the Yonsei University College of Medicine.
Author information
Authors and Affiliations
Contributions
CK supervised the study and JC designed the study. SW wrote the original draft and analyzed the data. Validation: YN, S-BK, S-KL, JL, HHK, and S-YK. Conceptualization: JC and CK. Writing, review and editing: JC and CK. Funding acquisition: CK.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Woo, S., Noh, Y., Koh, SB. et al. Associations of ambient manganese exposure with brain gray matter thickness and white matter hyperintensities. Hypertens Res 46, 1870–1879 (2023). https://doi.org/10.1038/s41440-023-01291-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41440-023-01291-1
Keywords
This article is cited by
-
Determinants and clinical implication of hypertension from childhood to old age in Asian subjects
Hypertension Research (2023)
-
Manganese exposure is a risk for brain atrophy
Hypertension Research (2023)